Incannex to Acquire APIRx Pharmaceuticals USA, LLC
- Thursday, March 24, 2022, 7:00
- Finance
- Add a comment
Highlights: APIRx has twenty-two (22) active clinical and pre-clinical research and development projects therapeutic candidates are targeted at treating pain, dementia, Parkinson’s disease, restless leg syndrome, gastrointestinal diseases, periodontitis, addiction disorders, skin…
About the Author
adminasapcorp has written 41779 stories on this site.